The role of growth factor receptors in viral infections: An opportunity for drug repurposing against emerging viral diseases such as COVID-19?

被引:46
作者
Hondermarck, Hubert [1 ,2 ]
Bartlett, Nathan W. [1 ,2 ]
Nurcombe, Victor [3 ,4 ]
机构
[1] Univ Newcastle, Sch Biomed Sci & Pharm, Fac Hlth & Med, Callaghan, NSW, Australia
[2] Univ Newcastle, Hunter Med Res Inst, New Lambton Hts, NSW, Australia
[3] ASTAR, Inst Med Biol, Glycotherapeut Grp, Singapore, Singapore
[4] Nanyang Technol Univ, Imperial Coll London, Lee Kong Chian Sch Med, Singapore, Singapore
关键词
cancer drugs; COVID-19; growth factors; heparan sulfate; heparin; inhibitors; SARS-CoV-2; tyrosine kinase; virus; HERPES-SIMPLEX-VIRUS; HEPARAN-SULFATE; CYTOKINE PRODUCTION; HOST FACTORS; CORONAVIRUS; CELLS; ENTRY; REPLICATION; ACTIVATION; BINDING;
D O I
10.1096/fba.2020-00015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Growth factor receptors are known to be involved in the process of viral infection. Many viruses not only use growth factor receptors to physically attach to the cell surface and internalize, but also divert receptor tyrosine kinase signaling in order to replicate. Thus, repurposing drugs that have initially been developed to target growth factor receptors and their signaling in cancer may prove to be a fast track to effective therapies against emerging new viral infections, including the coronavirus disease 19 (COVID-19).
引用
收藏
页码:296 / 303
页数:8
相关论文
共 64 条
  • [1] [Anonymous], 2015, RECEPTOR TYROSINE KI
  • [2] BAIRD A, 1990, NATURE, V348, P344, DOI 10.1038/348344a0
  • [3] Transforming Growth Factor-β Signaling in Immunity and Cancer
    Batlle, Eduard
    Massague, Joan
    [J]. IMMUNITY, 2019, 50 (04) : 924 - 940
  • [4] Vaccinia virus hijacks EGFR signalling to enhance virus spread through rapid and directed infected cell motility
    Beerli, Corina
    Yakimovich, Artur
    Kilcher, Samuel
    Reynoso, Glennys, V
    Flaeschner, Gotthold
    Mueller, Daniel J.
    Hickman, Heather D.
    Mercer, Jason
    [J]. NATURE MICROBIOLOGY, 2019, 4 (02) : 216 - 225
  • [5] Ephrin receptor A2 is a functional entry receptor for Epstein-Barr virus
    Chen, Jia
    Sathiyamoorthy, Karthik
    Zhang, Xianming
    Schaller, Samantha
    White, Bethany E. Perez
    Jardetzky, Theodore S.
    Longnecker, Richard
    [J]. NATURE MICROBIOLOGY, 2018, 3 (02): : 172 - 180
  • [6] Drug therapy: EGFR antagonists in cancer treatment
    Ciardiello, Fortunato
    Tortora, Giampaolo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (11) : 1160 - 1174
  • [7] Origins of Growth Factors: NGF and EGF
    Cohen, Stanley
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (49) : 33793 - 33797
  • [8] Reciprocal Effects of Fibroblast Growth Factor Receptor Signaling on Dengue Virus Replication and Virion Production
    Cortese, Mirko
    Kumar, Anil
    Matula, Petr
    Kaderali, Lars
    Scaturro, Pietro
    Erfle, Holger
    Acosta, Eliana Gisela
    Buehler, Sandra
    Ruggieri, Alessia
    Chatel-Chaix, Laurent
    Rohr, Karl
    Bartenschlager, Ralf
    [J]. CELL REPORTS, 2019, 27 (09): : 2579 - +
  • [9] Murine coronavirus with an extended host range uses heparan sulfate as an entry receptor
    de Haan, CAM
    Li, Z
    Lintelo, ET
    Bosch, BJ
    Haijema, BJ
    Rottier, PJM
    [J]. JOURNAL OF VIROLOGY, 2005, 79 (22) : 14451 - 14456
  • [10] Afatinib in advanced NSCLC: a profile of its use
    Deeks E.D.
    Keating G.M.
    [J]. Drugs & Therapy Perspectives, 2018, 34 (3) : 89 - 98